Creutzfeldt-Jakob disease: A rare cause of dementia in elderly persons

Clinical Infectious Diseases

Volumn 43, Issue 3, 2006, Pages 340-346

  Knight, Richard ^a,b  

^a National Creutzfeldt Jakob Disease Surveillance Unit   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; HUMAN GROWTH HORMONE; PRION PROTEIN;

AGE; ALEUTIAN MINK DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; CLINICAL FEATURE; CONFORMATIONAL TRANSITION; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DISEASE TRANSMISSION; FATAL FAMILIAL INSOMNIA; GENE; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HIGH RISK POPULATION; HUMAN; IATROGENIC DISEASE; KURU; NONHUMAN; PATHOGENESIS; PRION DISEASE; PRIORITY JOURNAL; PRNP GENE; PROTEIN CONFORMATION; REVIEW; RISK FACTOR; SCRAPIE; SYMPTOM; ZOONOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CREUTZFELDT-JAKOB SYNDROME; DEMENTIA; HUMANS; MIDDLE AGED; PRION DISEASES;

EID: 33746098164     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/505215     Document Type: Review

References (35)

1. Katscher F. It's Jakob's disease, not Creutzfeldt's. Nature 1998; 393:11.
2. Prusiner SB. An introduction to prion biology and diseases. In: Prusiner SB, ed. Prion biology and Diseases. New York: Cold Spring Harbour Laboratory Press, 2004:1-87.
3. Prusiner SB. Development of the prion concept. In: Prusiner SB, ed. Prion biology and diseases. New York: Cold Spring Harbour Laboratory Press, 2004:89-141.P.
4. Ironside JW. General features of prion diseases. In: Clark CM, Trojanowski JQ, eds. Neurodegenerative diseases. USA: McGraw-Hill, 2000: 329-40.
5. DeArmond SJ, Ironside JW, Bouzamondo-Bernstein E, Peretz D, Fraser JR. Neuropathology of prion diseases. In: Prusiner SB, ed. Prion biology and diseases. New York: Cold Spring Harbour Laboratory Press, 2004: 777-856.
6. Prusiner SB, Scott MR, DeArmond SJ, Carlson G. Transmission and replication of prions. In: Prusiner SB, ed. Prion biology and diseases. New York: Cold Spring Harbour Laboratory Press, 2004:187-242.
7. Head MW, Bunn TJR, Bishop MT, et al. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann Neurol 2004; 55:851-9.
8. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46:224-33.
9. Polymenidou M, Stoeck K, Glatzel M, Vey M, Bellon A, Aguzzi A. Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet 2005; 4:795.
10. Windl O, Dempster M, Estibeiro, et al. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 1996; 98:259-64.
11. Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RSG, Budka H. Mutations of the prion protein gene: phenotypic spectrum. J Neurol 2002; 249:1567-82.
12. Will RG, Alpers MP, Dormont D, Schonberger LB. Infectious and sporadic prion diseases. In: Prusiner SB, ed. Prion biology and diseases. New York: Cold Spring Harbor Laboratory Press, 2004:629-71.
13. The 13th National Creutzfeldt-Jakob Disease Surveillance Unit annual report. 2004.
14. Ward HJT, Everington D, Croes EA, et al. Sporadic Creutzfeldt-Jakob disease and surgery: A case-control study using community controls. Neurology 2002; 59:543-8.
15. Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 1999; 353:693-7.
16. De Silva R, Findlay C, Awad I, Harries-Jones R, Knight R, Will R. Creutzfeldt-Jakob disease in the elderly. Postgrad Med J 1997; 73:557-9.
17. Henry C, Lowman A, Will RG. Creutzfeldt-Jakob disease in elderly people. Age Ageing 2002; 31:7-10.
18. Knight R, Brazier M, Collins SJ. Human prion diseases: cause, clinical and diagnostic aspects. In: Rabenau HF, Cinatl J, Doerr HW, eds. Prions: a challenge for science, medicine and the public health system. Basel, Switzerland: Karger 2004; 72-97.
19. Yull HM, Ritchie DL, Langeveld JPM, et al. Detection of type 1 prion protein in variant Creutzfelt-Jakob disease. Am J Pathol 2006; 168: 151-7.
20. Brown P, Preece M, Brandel J-P, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000; 55:1075-81.
21. Llewelyn CA, Hewitt PA, Knight RSG, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363:417-21.
22. Peden AH, Head MW Ritchie DL, Bell JE, Ironside JW. Predinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364:527-9.
23. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347:921-5.
24. Knight R. The relationship between new variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Vox Sang 1999; 76:203-8.
25. The National Creutzfeldt-Jakob Disease Surveillance Unit annual report. 2005.
26. Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998; 352:703-4.
27. Hilton DA, Ghani AC, Conyers L, et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004; 203: 733-9.
28. Spencer MD, Knight RSG, Will RG. First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ 2002; 324:1479-82.
29. World Health Organization (WHO). WHO Manual for Strengthening Diagnosis and Surveillance of Creutzfeldt-Jakob disease. Geneva: WHO, 1998.
30. World Health Organization (WHO). The revision of the surveillance case definition for variant Creutzfeldt-Jakob disease (vCJD). Geneva: WHO, 2002.
31. Zerr I, Pocchiari M, Collins S, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000; 55:811-5.
32. Finkenstaedt M, Szudra A, Zerr I, et al. MR imaging of Creutzfeldt-Jakob disease. Radiology 1996; 199:793-8.
33. Collie DA, Sellar RJ, Zeidler M, Colchester AFC, Knight R, Will RG. MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. Clinical Radiology 2001; 56:726-39.
34. Green AJE, Thompson EJ, Stewart GE, et al. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2001; 70:744-8.
35. Collie DA, Summers DM, Sellar RJ, et al. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. Am J Neuroradiol 2003; 24: 1560-9.